|
||
|
Pentz RD , Flamm AL, Sugarman J, Cohen MZ, Ayers GD, Herbst RS, Abbruzzese JL. Potential Participants’ Perceptions of a High-Profile Phase I Trial. Journal of Clinical Oncology. 2002: 20:3785-3791. Grégoire V, Ang KK, Beauduin M., Garden AS, Hamoir M, Hittelman WN, Humblet Y, Khuri FR, Milas L, Mitine C, Scalliet P. A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma. Radiotherapy & Oncology, 63(2): 187-93, 2002. Shin DM, Glisson BS, Khuri FR, Clifford JL, Clayman G, Benner SE, Forastiere AA, Ginsberg L, Liu D, Lee D, Lee JJ, Myers J, Goepfert H, Lotan R, Hong WK, Lippman, SM. Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer. Journal of Clinical Oncology, 20(2): 364-370, 2002. Glisson BS, Murphy BA, Frenette G, Khuri FR, Forastiere AA. Phase II trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck. Journal of Clinical Oncology, 20(6): 1593-1599, 2002. Yang, C.S., Maliakal, P., and Meng, X. Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol., 42: 25-54, 2002. Li, N., Chen, X., Liao, J., Yang, G-Y., Wang, S., Josephson, Y., Han, C., Chen, J., Huang, M-T., and Yang, C.S. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA) -induced oral carcinogenesis in hamsters by tea and curcumin. Carcingoenesis, 23: 1307-1313, 2002. Meng, X., Lu, H., Lee, M-J., Zhu, N., Sheng, S., Ho, C-T., and Yang, C.S. Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chemical Res. Toxicol. 15: 1042-1050, 2002. Sun, C-L., Yuan, J-M., Lee, M-J., Yang, C.S., Gao, Y-T., Ross, R.K., and Yu, M.C. Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. Carcinogenesis, 23: 1497-1503, 2002. Lu, Y-P., Lou, Y-R., Xie, J-G., Peng, Q-Y., Liao, J., Yang, C.S., Huang, M-T., and Conney, A.H. Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc. Nat. Acad. Sci., 99: 12455-12460, 2002. Lee, M-J., Maliakal, P., Chen, L., Meng, X., Bondoc, F.Y., Prabhu, S., Lambert, G., Mohr, S., and Yang, C.S. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomark. Prev. 11: 1025-1032, 2002. Hong, J-I., Lu, H., Meng, X.F., Ryu, J-H., Hara, Y. and Yang, C.S. Stability, cellular uptake, biotransformation and efflux of tea polyphenol (-)-epigallocatechin-3-gallate in ht-29 human colon adenocarcinoma cells. Cancer Res. 62: 7241-7246, 2002. Hurwitz, S.J. & Schinazi, R.F., 2002. Development of a pharmacodynamic model for HIV treatment with nucleoside reverse transcriptase and protease inhibitors. Antiviral Res. 56:115-127. Hurwitz, S.J., Tennant, B.C., Korba, B.E., Gerin, J.L., Liberman, I., & Schinazi, R.F., 2002. Viral pharmacodynamics of (-)-β-2',3'-dideoxy-5-fluoro-3' Guan B, Yue P, Lotan R. Sun S-Y. Evidence that the human death receptor 4 is regulated by activator protein 1. Oncogene, 21: 3121-3129, 2002. (The sequence of DR4 5’ upstream region was deposited in Genebank as AY033911). Sun S-Y, Yue P, Chen X, Hong WK, Lotan R. The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells. Cancer Res, 62: 2430-2436, 2002. Kim KB, Lotan R, Yue P, Sporn MB, Suh N, Gribble GW, Honda T, Wu GS, Hong WK, Sun S-Y. Identification of a novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1,9-dien-28-oate that potently induces caspase-mediated apoptosis in human lung cancer cells. Mol Cancer Ther, 1: 177-184, 2002. Truong, A. B., Masters, S. C., Yang, H., and Fu, H. Role of the 14-3-3 C-terminal loop in ligand interaction. Proteins, 49: 321-325, 2002. |
|
Jimenez-Barbero, J., Amat-Guerri, F., and Snyder, J. P. The solid state, solution and tubulin-bound conformations of agents that promote microtubule stabilization. Curr Med Chem Anticancer Agents, 2: 91-122, 2002. 26. Lakdawala, A. S., Morgan, D. M., Liotta, D. C., Lynn, D. G., and Snyder, J. P. Dynamics and fluidity of amyloid fibrils: a model of fibrous protein aggregates. J Am Chem Soc, 124: 15150-15151, 2002. Rogatko, A., Slifker, M. J., and Babb, J. S. Hardy-Weinberg equilibrium diagnostics. Theor Popul Biol, 62: 251-257, 2002. Shin, D. M., Glisson, B. S., Khuri, F. R., Lippman, S. M., Ginsberg, L., Diaz, E., Jr., Papadimitrakopoulou, V., Feng, L., Francisco, M., Garden, A., Kies, M. S., Myers, J., Clayman, G., and Hong, W. K. Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Cancer, 95: 322-330, 2002. Maxwell, D. J., Taylor, J. R., and Nie, S. Self-assembled nanoparticle probes for recognition and detection of biomolecules. J Am Chem Soc, 124: 9606-9612, 2002. Chan, W. C., Maxwell, D. J., Gao, X., Bailey, R. E., Han, M., and Nie, S. Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotechnol, 13: 40-46, 2002. Gao, X., Chan, W. C., and Nie, S. Quantum-dot nanocrystals for ultrasensitive biological labeling and multicolor optical encoding. J Biomed Opt, 7: 532-537, 2002.
Vigneswaran, N. and Muller, S. Oral and maxillofacial pathology case of the month. Dentin dysplasia type I. Tex Dent J, 119: 1209, 1216, 2002.
|
||
| Last update: July 31st, 2008 by Robert Fu & Edwin Shin |
||